ALNY vs CDXS · P/E 76, rev $1.29B vs rev $30.2M
Alnylam Pharmaceuticals Inc (ALNY) versus Codexis Inc (CDXS) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Codexis Inc (CDXS) is a biotechnology company listed on US.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported CDXS revenue for 2026-06-30 was $30.2M. Net income was -$20.7M. Revenue was up 97.8% from 2026-03-31 to 2026-06-30. CDXS currently screens at market cap $257.6M.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. CDXS currently screens at market cap $257.6M.
Not investment advice. Open the ALNY and CDXS stock pages for the full models.
Not investment advice.